Status:
SUSPENDED
COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment
Lead Sponsor:
Erasmus Medical Center
Conditions:
Covid19
Cardiac Arrest
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
During the Corona Virus Pandemic health care resources have become scare, and the pandemic has brought forth the need for risk stratification of patients suffering from COVID19 in order to allocate re...
Detailed Description
Disease resulting from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a high mortality rate with deaths predominantly caused by respiratory failure. As of 1 September ...
Eligibility Criteria
Inclusion
- adults with COVID19 (proven by polymerase chain reaction, or with strong clinical suspicion based on clinical features and/or radiodiagnostics)
Exclusion
- minors
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04743232
Start Date
March 1 2021
End Date
January 31 2025
Last Update
February 15 2023
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
OLVG
Amsterdam, North Holland, Netherlands, 1091AC
2
Maasstad Ziekenhuis
Rotterdam, South Holland, Netherlands, 3079DZ
3
Amsterdam UMC
Amsterdam, Netherlands
4
Rijnstate
Arnhem, Netherlands